Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Donovan Joanne M.
CMO at Edgewise Therapeutics. Filing since 2 May 2023.
CIK 0001644087
Company
Date
Role
Action
Shares
Amount
Of holding
EWTX
Edgewise Therapeutics, Inc.
13 Aug 2026
CMO
Sold at will
2,919
$126.70K
25.3%
EWTX
Edgewise Therapeutics, Inc.
12 Aug 2026
CMO
Sold at will
6,522
$286.00K
36.1%
EWTX
Edgewise Therapeutics, Inc.
5 May 2026
CMO
Sold at will
50,000
$1.93M
92.0%
EWTX
Edgewise Therapeutics, Inc.
4 May 2026
CMO
Sold at will
5,230
$163.66K
54.5%
EWTX
Edgewise Therapeutics, Inc.
1 Apr 2026
CMO
Sold on a plan
28,662
$926.10K
74.9%
EWTX
Edgewise Therapeutics, Inc.
31 Mar 2026
CMO
Sold on a plan
21,338
$685.31K
69.0%
EWTX
Edgewise Therapeutics, Inc.
27 Mar 2026
CMO
Sold on a plan
16,358
$506.73K
63.0%
EWTX
Edgewise Therapeutics, Inc.
12 Aug 2025
CMO
Sold at will
2,862
$38.33K
10.1%
EWTX
Edgewise Therapeutics, Inc.
2 May 2025
CMO
Sold at will
5,187
$85.35K
19.4%
EWTX
Edgewise Therapeutics, Inc.
28 Jan 2025
CMO
Sold on a plan
25,000
$690.66K
60.4%
EWTX
Edgewise Therapeutics, Inc.
20 Sep 2024
CMO
Sold at will
7,162
$202.60K
33.0%
EWTX
Edgewise Therapeutics, Inc.
2 May 2024
CMO
Sold at will
3,682
$69.63K
15.6%
EWTX
Edgewise Therapeutics, Inc.
2 May 2023
CMO
Sold at will
3,254
$28.98K
24.6%
13 decisions on file.
